Merck Financials

Market Capitalization $244.44 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	20.22
Forward PE	10.28
Price to Sales TTM	$3.87
Price to Book MRQ	$5.50
Enterprise to Revenue	4.24
Enterprise to EBITDA	11.69

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	19.23%
Operating Margin	26.20%
Return on Assets TTM	10.53%
Return on Equity TTM	28.33%

Income Statement

Revenue TTM	$63,174,000,640
Revenue per Share TTM	$24.93
Quarterly Revenue Growth	4.40%
Gross Profit TTM	$48,388,001,792
EBITDA	$7,536,000,000
Net Income to Common TTM	$12,147,999,744
Diluted EPS TTM	$4.78
Quarterly Earnings Growth YoY	-33.50%

Balance Sheet

Total Cash MRQ	$14,593,000,448
Total Cash per Share MRQ	$5.77
Total Debt MRQ	$
Total Debt to Equity MRQ	85.57
Current Ratio MRQ	1.36
Book Value per Share MRQ	$17.58

Cash Flow

Operating Cash Flow TTM	$18,264,000,512
Levered Free Cash Flow TTM	$14,019,624,960

MRK Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	2,529,639,936
Float Shares	2,525,031,708
Avg 10 Volume	11,452,050
Avg 30 Volume	None
Shares Short	30,926,600
Short Ratio	2.64
Short % of Shares	1.22%
% Held by Insiders	0.06%
% Held by Institutions	79.39%

Stock Price Summary

Beta	0.41
Fifty Two Week Low	$94.48
Fifty Two Week High	$134.63
Fifty Two Week Change	-26.93%
Day 50 MA	$99.78
Day 200 MA	$115.28

Dividends and Splits

Forward Annual Dividend Rate	$3.24
Forward Annual Dividend Yield	3.39%
Trailing Annual Dividend Rate	$3.12
Trailing Annual Dividend Yield	3.27%
Payout Ratio	64.44%
Dividend Date	2025-01-08
Ex Dividend Date	2024-12-16
Last Split Factor
Last Split Date	2021-06-03